Skip to content

Mobile Application for Self-Management of Type 2 Diabetes Mellitus

Mobile Application for Self-Management of Type 2 Diabetes Mellitus: Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06176703
Enrollment
128
Registered
2023-12-20
Start date
2023-11-22
Completion date
2025-11-22
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The goal of this Randomized Controlled Trial is to study the effect of mobile Application on glycemic control of type2 diabetes mellitus. The main questions aim to answer are: * The effect of mobile application on glycemic control and quality of life of diabetes mellitus patients * The satisfaction of mobile application of diabetes mellitus patients who used it Participants will be received education about diabetes mellitus and separated into two groups, intervention group(using mobile application) and control group(not using mobile application but also receive standard treatment of diabetes mellitus. Researchers will compare intervention group to control group about glycemic control including HbA1c, complications of diabetes mellitus etc. and quality of life.

Interventions

DEVICEmobile application

using mobile application along with standard treatment of diabetes mellitus

Sponsors

Ramathibodi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Type2 diabetes mellitus who have HbA1c above 7% * Can use application on smartphone * age 18 years old or more (relatives are accept if participants have age more than 65 years old and cannot use smartphone) * consent to participate the research

Exclusion criteria

* refuse to participate the research * pregnancy * using continuous glucose monitoring system or insulin pump * disability in sight or hearing * have been using the mobile application(RAMAdiabetes) in the past

Design outcomes

Primary

MeasureTime frameDescription
Glycemic control3-6 monthsHbA1c

Secondary

MeasureTime frameDescription
self-diabetes management3-6 monthsThe Thai-Diabetes Management of Self-Efficacy Scale(T-DMSES), total score range from 19 to 95 points(minimum to maximum), each question has 1 to 5 points, higher scores mean better self diabetes management
Quality of life3-6 monthsThe Thai version of the EQ-5D-5L Health Questionnaire

Countries

Thailand

Contacts

Primary ContactSupasuta Wongdama, Fellowship
poytriplet@gmail.com0905754190

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026